Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
The Kroger Co.
KR
5
Eli Lilly and Co
LLY
US Stock MarketDetailed Quotes
VXRT Vaxart
- 0.4680
- +0.0673+16.80%
Trading Apr 28 10:34 ET
106.80MMarket Cap-1.42P/E (TTM)
0.4777High0.4349Low2.51MVolume0.4382Open0.4007Pre Close1.16MTurnover1.11%Turnover RatioLossP/E (Static)228.21MShares1.070052wk High1.81P/B105.96MFloat Cap0.285052wk Low--Dividend TTM226.41MShs Float24.9000Historical High--Div YieldTTM10.68%Amplitude0.2543Historical Low0.4600Avg Price1Lot Size
About Vaxart Company
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.
Company Profile
SymbolVXRT
Company NameVaxart
Listing DateDec 1, 1969
Issue Price8.00
Founded2004
CEOMr. Steven Lo
MarketNASDAQ
Employees105
Fiscal Year Ends12-31
Address170 Harbor Way,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-550-3500
Websitehttp://www.vaxart.com
Company Executives
- Name
- Position
- Salary
- Steven Lo
- Director, President and Chief Executive Officer
- 2.09M
- Phillip E. Lee
- Chief Financial Officer and Principal Accounting Officer
- --
- James F. Cummings
- Chief Medical Officer
- 1.21M
- Dr. Sean N. Tucker, PhD
- Senior Vice President and Chief Scientific Officer
- 1.16M
- Edward B. Berg
- Senior Vice President and General Counsel
- --
- Dr. Michael J. Finney, PhD
- Chairman of the Board
- 305.39K
- Kevin P. Finney
- Independent Director
- --
- W. Mark Watson
- Independent Director
- 142.88K
- Dr. Elaine J. Heron, M.B.A.,PhD
- Independent Director
- 143.78K
- Dr. David E. Wheadon, M.D.
- Lead Independent Director
- 146.98K
Market Insights
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.
Unlock Now
Discussing
關稅風暴暫離高壓區！市場能否迎來反彈？
當地時間4月22日，美國總統特朗普公開承認美國目前對中國出口商品的關稅過高，預計稅率將大幅降低；美國財政部長貝森特也表示中美雙方關稅戰將很快降溫。4月25日，特朗普表示將爲不同國家設定「公平的」關稅稅率。特朗普此次對華關稅態度的轉變，能否平息市場恐慌情緒？關稅拉鋸戰最終結局如何？
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th